Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT05156983

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Led by Takeda · Updated on 2026-01-28

328

Participants Needed

64

Research Sites

294 weeks

Total Duration

On this page

Sponsors

T

Takeda

Lead Sponsor

T

Takeda Development Center Americas, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagulation reversal in participants treated with Factor Xa inhibitors who require urgent surgery/invasive procedure. The participant will be assigned by chance to either TAK-330 or SOC 4F-PCC as part of standard treatment before surgery. Patients participating in this study will need to be hospitalized. They will also be contacted (via telehealth/phone call) 30 days after the surgery.

CONDITIONS

Official Title

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant or legally authorized representative willing to sign e-consent/written informed consent form.
  • Participants at least 18 years of age at enrollment.
  • Participant currently on treatment with oral Factor Xa inhibitor (rivaroxaban, apixaban, edoxaban).
  • Participant requires urgent surgery/procedure with high risk of intraoperative bleeding within 15 hours from last Factor Xa inhibitor dose, or has elevated plasma anti-Factor Xa levels if beyond 15 hours.
  • Women of childbearing potential must have a negative pregnancy test prior to enrollment.
Not Eligible

You will not qualify if you...

  • Expected survival less than 30 days despite best medical and surgical care.
  • Recent (within 90 days) history of venous thromboembolism, myocardial infarction, disseminated intravascular coagulation, ischemic stroke, transient ischemic attack, unstable angina hospitalization, or severe/critical COVID-19 infection.
  • Active major bleeding requiring surgery or transfusion of more than 2 units of packed red blood cells or intracranial hemorrhage (except certain subdural hemorrhages with GCS ≥9).
  • Polytrauma where Factor Xa reversal alone is insufficient for hemostasis.
  • Known prothrombotic disorders such as antiphospholipid syndrome or protein C/S deficiency.
  • Known bleeding disorders like platelet function disorders, hemophilia, Von Willebrand disease, or coagulation factor deficiency.
  • Platelet count less than 50,000 per microliter.
  • History of heparin-induced thrombocytopenia.
  • Use of certain procoagulant drugs or blood products within 7 days before enrollment, except specified exceptions.
  • Planned use of procoagulant drugs or blood products after enrollment but before 24±4 hour hemostatic assessment.
  • Administration of heparin within 2 hours or low molecular weight heparin within 6 hours before randomization.
  • Hypersensitivity to PCC or TAK-330 ingredients.
  • History of IgA deficiency with hypersensitivity and antibodies to IgA.
  • Septic shock requiring vasopressors and elevated blood lactate despite resuscitation.
  • Acute or chronic liver failure (Child-PUGH score C).
  • Renal failure requiring dialysis.
  • Conditions posing undue risk as judged by investigator.
  • Participation in another investigational product/device trial within 30 days or planned during this study.
  • Use of PROTHROMPLEX TOTAL as SOC 4F-PCC.
  • Women breastfeeding at enrollment.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 64 locations

1

University of Arkansas Medical Sciences

Arkansas City, Arkansas, United States, 72205

Actively Recruiting

2

University of California Davis Health System

Sacramento, California, United States, 95817

Actively Recruiting

3

Denver Metro Orthopedics, P.C.

Englewood, Colorado, United States, 80012

Actively Recruiting

4

University of Florida

Gainesville, Florida, United States, 32608

Actively Recruiting

5

Rutgers, The State University of New Jersey

New Brunswick, New Jersey, United States, 07103

Actively Recruiting

6

ECU Health Medical Center

Greenville, North Carolina, United States, 27858

Actively Recruiting

7

Metro Health Medical Center

Cleveland, Ohio, United States, 44109

Actively Recruiting

8

Ohio State University

Columbus, Ohio, United States, 43210

Actively Recruiting

9

Ascension St. John Medical Center

Tulsa, Oklahoma, United States, 74104

Actively Recruiting

10

University of Pennsylvania - Perelman School of Medicine

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

11

UPMC

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

12

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Actively Recruiting

13

Carilion Medical Center

Virginia Beach, Virginia, United States, 24014

Actively Recruiting

14

Hospital Universitario Austral

Buenos Aires, Argentina, B1629WWA

Actively Recruiting

15

Clinica Zabala

Ciudad Autonoma Buenos Aires, Argentina, 1426

Actively Recruiting

16

Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia - FLENI

Ciudad Autonoma Buenos Aires, Argentina, CP1428

Actively Recruiting

17

Hospital Privado de Rosario

Santa Fe, Argentina, 3000

Actively Recruiting

18

LKH - Universitaetsklinikum Graz

Graz, Austria, 8036

Actively Recruiting

19

Landesklinikum Neunkirchen

Neunkirchen, Austria, 2620

Actively Recruiting

20

ZOL

Genk, Limburg, Belgium, 3600

Actively Recruiting

21

Jessa Ziekenhuis Hospital

Hasselt, Limburg, Belgium, 3500

Actively Recruiting

22

AZ Groeninge

Kortrijk, Belgium, 8500

Actively Recruiting

23

CHU UCL Namur

Therasse 1, Belgium, 5530

Actively Recruiting

24

Irmandade da Santa Casa da Misericordia de Santos

Santos, São Paulo, Brazil, 11010-000

Actively Recruiting

25

Hospital de Clinicas de Ijui

Ijuí, Brazil, 98700-000

Actively Recruiting

26

Hospital Sao Paulo

São Paulo, Brazil, 5102

Actively Recruiting

27

Hamilton General Hospital

Hamilton, Ontario, Canada, L8L 2X2

Actively Recruiting

28

London Health Sciences Centre (LHSC) - University Hospital

London, Ontario, Canada, N6A 5A5

Actively Recruiting

29

Unity Health Toronto St Michaels Hospital

Toronto, Ontario, Canada, M5N 1W8

Actively Recruiting

30

Montreal General Hospital

Montreal, Quebec, Canada, H3G 1A4

Actively Recruiting

31

The Ottawa Hospital - General Campus

Ontario, Canada, K1H 8L6

Actively Recruiting

32

CHU de Quebec- Hopital de l Enfant Jesus

Québec, Canada, G1J-1Z4

Actively Recruiting

33

Fakultni nemocnice Brno

Jihlavska, Czechia, 625 00

Actively Recruiting

34

Fakultni nemocnice v Motole

Prague (Praha), Czechia, 15000

Actively Recruiting

35

Dept of II. interni klinika - gastroenterologie

Srobarova C, Czechia, 100 34

Actively Recruiting

36

CHU Strasbourg - Hopital Hautepierre

Strasbourg, Bas Rhin, France, 67098

Actively Recruiting

37

Hospital michallon - CHUGA

Grenoble, France, 38043

Completed

38

Hopital Marie Lannelongue

Le Plessis-Robinson, France, 92350

Completed

39

Hôpital Lariboisière

Paris, France, 75010

Completed

40

GH Paris Saint Joseph

Paris, France, 75014

Actively Recruiting

41

BG Klinikum Murnau gGmbH

Murnau am Staffelsee, Bavaria, Germany, 82418

Actively Recruiting

42

Universitaetsklinikum Carl Gustav Carus TU Dresden

Dresden, Saxony, Germany, 01307

Actively Recruiting

43

Universitaetsklinikum Leipzig AoeR

Leipzig, Saxony, Germany, 04103

Actively Recruiting

44

Klinikum Dortmund gGmbH

Murnau am Staffelsee, Germany, 44137

Actively Recruiting

45

Konstantopoulio General Hospital, N.Ionia

Nea Ionia, Attica, Greece, 14233

Actively Recruiting

46

Bekes Varmegyei Kozponti Korhaz

Békéscsaba, Attica, Hungary, 5700

Actively Recruiting

47

Ozdi Almasi Balogh Pal Korhaz

Szeged, Attica, Hungary, 6725

Actively Recruiting

48

Semmelweis Egyetem

Budapest, Hungary, 1082

Actively Recruiting

49

Debreceni Egyetem

Debrecen, Hungary, 4032

Actively Recruiting

50

Shamir Medical Center (Assaf Harofe)

Beer Yaacov, Israel, 70300

Actively Recruiting

51

Soroka Medical Center

Beersheba, Israel, 8410101

Actively Recruiting

52

Rambam Health Care Campus

Haifa, Israel, 3109601

Actively Recruiting

53

Shaare Zedek Medical Center

Jerusalem, Israel, 9103102

Actively Recruiting

54

Hadassah University Hospital - Ein Kerem

Jerusalem, Israel, 911200

Actively Recruiting

55

Rabin MC

Petah Tikva, Israel, 49100

Actively Recruiting

56

Chaim Sheba Medical Center

Ramat Gan, Israel, 5265601

Actively Recruiting

57

Tel Aviv Sourasky Medical Center

Tel Aviv, Israel, 6423906

Actively Recruiting

58

Uniwersytecki Szpital Kliniczny nr 1 im. prof. Tadeusza Sokołowskiego PUM w Szczecinie

Szczecin, Poland, 71-252

Actively Recruiting

59

Centro Hospitalar do Baixo Vouga, E.P.E. - Unidade de Aveiro

Aveiro, Portugal, 3810-501

Actively Recruiting

60

Centro Hospitalar do Baixo Vouga, E.P.E. - Unidade de Aveiro

Aveiro, Portugal, 3814-501

Actively Recruiting

61

Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E

Rua Conceição Fernandes, Portugal, 4434-502

Actively Recruiting

62

Hospital Clinico Universitario de Salamanca

Salamnca, Salamanca, Spain, 37007

Actively Recruiting

63

Hospital Clinico Universitario de Valencia

Valencia, Spain, 46010

Actively Recruiting

64

Hospital Universitari i Politecnic La Fe

Valencia, Spain, 46026

Actively Recruiting

Loading map...

Research Team

T

Takeda Contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here